Skip to main content

Table 3 Values of mfERG in four quadrants in patients and control groups

From: Neurophysiological visual assessment in patients with idiopathic intracranial hypertension: visual evoked potential and multifocal field electroretinography

MfERG Quadrants

Patients (n = 30)

Controls (n = 30)

P-value

RT Q1 amplitude

11.59 (3.53)

18.97 (4.10)

< 0.001*

RT Q1 peak time

44.35 (4.38)

43.08 (2.95)

0.194

LT Q1amplitude

11.86 (4.76)

19.41 (3.34)

< 0.001*

LT Q1peak time

43.70 (2.94)

42.58 (3.04)

0.153

RT Q2 amplitude

13.94 (3.85)

18.42 (3.79)

< 0.001*

RT Q2 peak time

42.88 (3.14)

42.64 (2.95)

0.768

LT Q2 amplitude

12.85 (3.05)

19.55 (4.27)

< 0.001*

LT Q2 peak time

43.32 (3.25)

42.95 (2.19)

0.608

RT Q3 amplitude

13 (3.94)

19.44 (4.21)

< 0.001*

RT Q3 peak time

43.38 (3.29)

42.84 (3.09)

0.516

LT Q3 amplitude

13.08 (4.16)

19.35 (3.26)

< 0.001*

LT Q3 peak time

44.24 (2.62)

43.47 (3.29)

0.323

RT Q4 amplitude

10.31 (3.25)

18.14 (2.80)

< 0.001*

RT Q4 peak time

43.09 (2.96)

42.65 (2.65)

0.541

LT Q4 amplitude

9.95 (3.11)

18.64 (3.09)

< 0.001*

LT Q4 peak time

43.93 (3.42)

43.54 (3.16)

0.649

  1. mfERG: Multifocal electroretinography, P-value is significant if ˂ 0.05